Neuronetics, Inc.

For the period ended Dec 31, 2024. Filed Mar 27, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 27, 2025

STIM$2.01-7.8%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Item 8. Consolidated Statements of Cash Flows

Consolidated Statements of Cash Flows

(In thousands)


· · Years ended December 31,
· · 2024 · · 2023 · · 2022
Cash flows from Operating activities: · · · ·
Net loss	$(43,727)	$(30,189)	$(37,159)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	2,073	2,006	1,648
Capitalized software impairment	3,956	—	—
Allowance for credit losses	2,055	390	341
Inventory impairment	626	1,905	—
Share-based compensation	5,602	7,319	8,746
Non-cash interest expense	771	634	709
Cost of rental units purchased by customers	—	—	92
Loss on extinguishment of debt	4,427	—	—
Loss on disposal of property and equipment	28	—	—
Changes in certain assets and liabilities:
Accounts receivable, net	(3,727)	(8,831)	(6,658)
Inventory	3,150	(1,098)	(2,587)
Net investments in sales-type leases	997	1,193	1,114
Prepaid commission expense	(1,096)	(1,319)	(1,243)
Prepaid expenses and other assets	(1,155)	(2,845)	786
Accounts payable	(1,985)	2,029	(1,968)
Accrued expenses	(2,083)	(2,243)	6,604
Other liabilities	(66)	—	—
Deferred revenue	(843)	(989)	(1,164)
Net Cash used in Operating activities	(30,997)	(32,038)	(30,739)

Cash flows from Investing activities:
Purchases of property and equipment and capitalized software	(1,466)	(2,369)	(3,269)
Cash paid for acquisition, net of cash and restricted cash acquired	(2,553)	—	—
Repayment of notes receivable	1,606	1,047	10,000
Net Cash (used in) provided by Investing activities	(2,413)	(1,322)	6,731

Cash flows from Financing activities:
Payments of debt issuance costs	(2,624)	(1,104)	(91)
Proceeds from issuance of long-term debt	57,479	25,000	—
Proceeds from issuance of warrants	2,521	—	—
Repayment of long-term debt	(60,000)	(1,200)	—
Payment for debt extinguishment cost	(4,185)	—	—
Proceeds from exercises of stock options	1	1	298
Net Cash (used in) provided by Financing activities	(6,808)	22,697	207
Net decrease in Cash, Cash equivalents and Restricted cash	(40,218)	(10,663)	(23,801)
Cash and Cash equivalents, Beginning of Period	59,677	70,340	94,141
Cash, Cash equivalents and restricted cash, End of Period	$19,459	$59,677	$70,340

Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheet:
Cash and cash equivalents	18,459	59,677	70,340
Restricted cash in deposits and other assets	1,000	—	—
Total cash, cash equivalents and restricted cash	$19,459	$59,677	$70,340

Supplemental disclosure of cash flow information:
Cash paid for interest	$6,513	$4,790	$3,543
Transfer of inventory to property and equipment	$92	$210	$250
Supplemental disclosure of non-cash investing and financing activities:
Purchases of property and equipment and capitalized software in accounts payable and accrued expenses	$13	$239	$103
Reduction of accounts receivable in current and long-term notes receivable	$606	$6,468	$432

Notes to the consolidated financial statements

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.